← Back to Clinical Trials
Recruiting NCT07407426

NCT07407426 EEG-Guided Binaural Beat Audio to Reduce Performance-Related Stress and Improve Cognition

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07407426
Status Recruiting
Phase
Sponsor Texas Tech University Health Sciences Center
Condition Cognitive Abilities
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2026-04-07
Primary Completion 2027-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
EEG-guided binaural beat audioNon-binaural audio intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2026-04-07 with a primary completion date of 2027-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Performance-related stress can impair sustained attention, inhibitory control, and memory. This randomized, double-blinded, sham-controlled parallel-arm trial evaluates whether a 30-minute EEG-guided binaural beat audio intervention reduces subjective stress/performance anxiety and improves cognition, and whether it changes task-related brain reactivity measured by fMRI. The intervention uses real-time single-electrode EEG recorded over the left prefrontal cortex to dynamically adjust binaural beat frequencies to guide the brain toward a target state; the sham condition uses non-binaural music delivered through identical headphones. Adult music majors preparing for an upcoming concert will complete pre- and post-intervention fMRI sessions during cognitive/music tasks (Stop Signal Reaction Task, Music Reading Task, Music Memory Retrieval Task) and complete visual analog scales (VAS) assessing performance anxiety, stress, and related subjective states. The primary outcomes include fMRI task-related activity in stress-regulation regions (dlPFC, amygdala, hippocampus), behavioral inhibition indices from the stop-signal task, music memory retrieval accuracy, and VAS-reported stress/performance anxiety.

Eligibility Criteria

Inclusion Criteria: * Adults (18+ years) enrolled as undergraduate music majors at Texas Tech University * Currently preparing for an upcoming concert performance within the next 3 months * Able to read standard musical notation Exclusion Criteria: * Subjects with contraindications to undergo MRI after being screened by the TTNI safety screening sheet - specifically, Subjects with implanted devices that are not compatible with MRI including, but not limited to cardiac pacemakers, cardiac defibrillators, aneurysm clips, carotid artery vascular clamps, implanted nerve stimulators (neuron-stimulators also called TENS or wires), bone growth or bone fusion stimulators, cochlear implants, vagus nerve stimulators, filters for blood clots (Umbrella, Greenfield, bird's nest), embolization coils (e.g. Gianturco) in the brain, ocular implants, vascular stents, medication pumps, medication patches delivering medications, implanted limbs, ventricular shunts, metal joints, rods, plates, pins, screws, nails, or clips, penile implants, or contraceptives devices including IUDs, cervical pessaries and diaphragms Subjects who have undergone cataract surgery Subjects who have shrapnel or metal in the head, eyes or skin Subjects with a history of working with metal fragments ( or have had metal removed from eyes Subjects with gunshot wounds or BB gun injury Subjects with permanent metal body piercings or jewelry that cannot be removed Subjects who use hearing aids or have braces / permanent retainers that cannot be removed temporarily for the MRI scans Subjects with large tattoos in the head and neck area Subjects with claustrophobia Subjects who are currently pregnant or suspected to be pregnant * Physical, medical, neurological or psychiatric impairments (including substance abuse) * Current use of medications that could affect cognitive performance (including beta-blockers, stimulants, anxiolytics, antidepressants, or antipsychotics) * History of head injury resulting in loss of consciousness/history of brain surgery * History of diagnosed hearing impairment or use of hearing aids * Current or past diagnosis of epilepsy or seizure disorders * Unwillingness or inability to refrain from alcohol consumption 48 hours prior to the study visit * Unwillingness or inability to refrain from caffeine consumption 12 hours prior to the study visit * Current/past history of substance abuse * Pregnancy or possibility of pregnancy * Unwillingness or inability to follow written, on-screen, and verbal instructions given by the study team

Contact & Investigator

Central Contact

Chathurika S Dhanasekara, MD, PhD

✉ samudani.dhanasekara@ttuhsc.edu

📞 806 743 2378

Frequently Asked Questions

Who can join the NCT07407426 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cognitive Abilities. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07407426 currently recruiting?

Yes, NCT07407426 is actively recruiting participants. Contact the research team at samudani.dhanasekara@ttuhsc.edu for enrollment information.

Where is the NCT07407426 trial being conducted?

This trial is being conducted at Lubbock, United States.

Who is sponsoring the NCT07407426 clinical trial?

NCT07407426 is sponsored by Texas Tech University Health Sciences Center. The trial plans to enroll 32 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology